Wa. Briggs et al., CLINICOPATHOLOGICAL CORRELATES OF PREDNISONE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY, American journal of kidney diseases, 28(4), 1996, pp. 618-621
A 43-YEAR-OLD MAN with rapidly evolving renal failure from biopsy-prov
en human immunodeficiency virus (HIV)-associated nephropathy (HIVAN) a
nd superimposed thrombotic microangiopathic changes was treated with p
rednisone, His serum creatinine decreased from 7.5 to 3.9 mg/dL, and t
he 24-hour protein excretion decreased from 15.7 to 6.1 g over 6 to 8
weeks, As the prednisone was tapered, however, the creatinine began to
increase, and a repeat biopsy was done to assist with therapeutic dec
isions, The major differences from the pretreatment biopsy were marked
reductions in interstitial lymphocytes and macrophages and absence of
thrombotic microangiopathic lesions, This is the first report compari
ng pretreatment and posttreatment renal biopsy specimens and the findi
ngs provide some insight into the means by which prednisone exerts its
beneficial clinical effects acutely on this disease. (C) 1996 by the
National Kidney Foundation, Inc.